Pfizer seeks emergency use of COVID-19 vaccine in India
Pfizer India has become the first pharmaceutical firm to seek an emergency use authorization for its COVID-19 vaccine in India, which has the second highest number of coronavirus infections.
“Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization (EUA) for its COVID-19 vaccine in India,” Indian media reported on Sunday, referring to the Drugs Controller General of India (DCGI).
“Pfizer India has sought permission for emergency usage authorization of its COVID-19 from DGCI to import and market,” an official was quoted as saying.
Pfizer India is a subsidiary of the parent company Pfizer Inc., an American multinational pharmaceutical corporation based in New York.
The United Kingdom on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorization for its emergency use.
India has reported more 9.57 million COVID–19 cases, behind only the United States, with nearly 140,000 deaths.
Pezeshkian says seeking to prevent conflict expansion as Modi blasts Israel’s genocide
Putin: BRICS, not the West, will drive global economic prosperity
Party opposed to India’s stripping Kashmir’s autonomy wins key vote
Israel launches air strikes on Syria-Lebanon border crossing
Russia: Comprehensive deal with Iran will include defense, security ties
VIDEO | Israeli embassy shooting in Jordan leaves gunman dead, 3 police injured
VIDEO | Paris march in support of Palestine women
VIDEO | ICC issues arrest warrants for Israeli prime minister, ousted regime war minister
120 Palestinians perish as Israeli war machine keeps ravaging Gaza
VIDEO | Struggles of Palestinian women amidst war, displacement
VIDEO | Hezbollah rains attack drones down on elite Israeli brigade
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
